{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:39:50Z","timestamp":1793849990326,"version":"4.6.1"},"reference-count":126,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020963","name":"Moonshot Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) is a neurodegenerative disorder characterized by memory loss and personality changes, eventually leading to dementia. The pathological hallmarks of AD are senile plaques and neurofibrillary tangles, which comprise abnormally aggregated \u03b2-amyloid peptide (A\u03b2) and hyperphosphorylated tau protein. To develop preventive, diagnostic, and therapeutic strategies for AD, it is essential to establish animal models that recapitulate the pathophysiological process of AD. In this review, we will summarize the advantages and limitations of various mouse models of AD, including transgenic, knock-in, and injection models based on A\u03b2 and tau. We will also discuss other mouse models based on neuroinflammation because recent genetic studies have suggested that microglia are crucial in the pathogenesis of AD. Although each mouse model has its advantages and disadvantages, further research on AD pathobiology will lead to the establishment of more accurate mouse models, and accelerate the development of innovative therapeutics.<\/jats:p>","DOI":"10.3389\/fnmol.2022.912995","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T13:50:17Z","timestamp":1655819417000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":224,"title":["Mouse Models of Alzheimer\u2019s Disease"],"prefix":"10.3389","volume":"15","author":[{"given":"Miyabishara","family":"Yokoyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honoka","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00401-014-1254-6","article-title":"A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity","volume":"127","author":"Ahmed","year":"2014","journal-title":"Acta Neuropathol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/ana.410380414","article-title":"Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer\u2019s disease","volume":"38","author":"Arai","year":"1995","journal-title":"Ann. Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"eabb2639","DOI":"10.1126\/scitranslmed.abb2639","article-title":"Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer\u2019s disease","volume":"13","author":"Ayalon","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/78682","article-title":"Peripherally administered antibodies against amyloid \u03b2-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer\u2019s disease","volume":"6","author":"Bard","year":"2000","journal-title":"Nat. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e20200861","DOI":"10.1084\/jem.20200861","article-title":"Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer\u2019s disease","volume":"217","author":"Barth\u00e9lemy","year":"2020","journal-title":"J. Exp. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3233\/JAD-2011-110977","article-title":"Gantenerumab: a novel human anti-A\u03b2 antibody demonstrates sustained cerebral amyloid-\u03b2 binding and elicits cell-mediated removal of human amyloid-\u03b2","volume":"28","author":"Bohrmann","year":"2012","journal-title":"J. Alzheimers. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/s0896-6273(00)80230-5","article-title":"Familial Alzheimer\u2019s disease-linked presenilin 1 variants elevate A\u03b21-421-40 ratio in vitro and in vivo","volume":"17","author":"Borchelt","year":"1996","journal-title":"Neuron"},{"key":"B9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"12145","DOI":"10.1073\/pnas.0904866106","article-title":"Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer\u2019s disease","volume":"106","author":"Britschgi","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B11","doi-asserted-by":"publisher","first-page":"34457","DOI":"10.1074\/jbc.M111.229633","article-title":"Passive immunization with anti-Tau antibodies in two transgenic models: reduction of Tau pathology and delay of disease progression","volume":"286","author":"Chai","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S1474-4422(21)00375-6","article-title":"Variant-dependent heterogeneity in amyloid \u03b2 burden in autosomal dominant Alzheimer\u2019s disease: cross-sectional and longitudinal analyses of an observational study","volume":"21","author":"Chhatwal","year":"2022","journal-title":"Lancet. Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"21562","DOI":"10.1074\/jbc.M100710200","article-title":"Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695","volume":"276","author":"Chishti","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1016\/j.febslet.2006.06.021","article-title":"Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine","volume":"580","author":"Chohan","year":"2006","journal-title":"FEBS Lett."},{"key":"B15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nm0197-67","article-title":"Mutant presenilins of Alzheimer\u2019s disease increase production of 42-residue amyloid \u03b2-protein in both transfected cells and transgenic mice","volume":"3","author":"Citron","year":"1997","journal-title":"Nat. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ncb1901","article-title":"Transmission and spreading of tauopathy in transgenic mouse brain","volume":"11","author":"Clavaguera","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer\u2019s disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1001\/jamaneurol.2015.0607","article-title":"Targeting prodromal Alzheimer\u2019s disease with avagacestat: a randomized clinical trial","volume":"72","author":"Coric","year":"2015","journal-title":"JAMA Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.neuron.2012.10.029","article-title":"A plaque-specific antibody clears existing \u03b2-amyloid plaques in Alzheimer\u2019s disease mice","volume":"76","author":"DeMattos","year":"2012","journal-title":"Neuron"},{"key":"B20","doi-asserted-by":"publisher","first-page":"eaag0481","DOI":"10.1126\/scitranslmed.aag0481","article-title":"Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy","volume":"9","author":"DeVos","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A Phase 3 trial of semagacestat for treatment of Alzheimer\u2019s disease","volume":"369","author":"Doody","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.neurobiolaging.2003.08.008","article-title":"Inflammation occurs early during the A\u03b2 deposition process in TgCRND8 mice","volume":"25","author":"Dudal","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"B23","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/383710a0","article-title":"Increased amyloid-\u03b242(43) in brains of mice expressing mutant presenilin 1","volume":"383","author":"Duff","year":"1996","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","article-title":"Randomized trial of verubecestat for mild-to-moderate Alzheimer\u2019s disease","volume":"378","author":"Egan","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMoa1812840","article-title":"Randomized trial of verubecestat for prodromal Alzheimer\u2019s disease","volume":"380","author":"Egan","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"226ra30","DOI":"10.1126\/scitranslmed.3007901","article-title":"Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer\u2019s disease","volume":"6","author":"Fagan","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"B27","first-page":"307","article-title":"Microglial response to amyloid plaques in APPsw transgenic mice","volume":"152","author":"Frautschy","year":"1998","journal-title":"Am. J. Pathol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1038\/s41467-019-10428-1","article-title":"Factors other than hTau overexpression that contribute to tauopathy-like phenotype in rTg4510 mice","volume":"10","author":"Gamache","year":"2019","journal-title":"Nat. Commun."},{"key":"B29","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/373523a0","article-title":"Alzheimer-type neuropathology in transgenic mice overexpressing V717F \u03b2-amyloid precursor protein","volume":"373","author":"Games","year":"1995","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.mad.2003.12.002","article-title":"Alzheimer\u2019s A\u03b2 vaccination of rhesus monkeys (Macaca mulatta)","volume":"125","author":"Gandy","year":"2004","journal-title":"Mech. Ageing Dev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effects of A\u03b2 immunization (AN1792) in patients with AD in an interrupted trial","volume":"64","author":"Gilman","year":"2005","journal-title":"Neurology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.bbrc.2012.08.020","article-title":"Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. 1984","volume":"425","author":"Glenner","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease","volume":"349","author":"Goate","year":"1991","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ana.410410106","article-title":"Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer\u2019s disease","volume":"41","author":"G\u00f3mez-Isla","year":"1997","journal-title":"Ann. Neurol."},{"key":"B35","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1016\/S0021-9258(17)38495-8","article-title":"Microtubule-associated protein tau. A component of Alzheimer paired helical filaments","volume":"261","author":"Grundke-Iqbal","year":"1986","journal-title":"J. Biol. Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer\u2019s disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"B38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nm.4443","article-title":"Amyloid-\u03b2 plaques enhance Alzheimer\u2019s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation","volume":"24","author":"He","year":"2018","journal-title":"Nat. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/brain\/awab289","article-title":"Development of a novel tau propagation mouse model endogenously expressing 3 and 4 repeat tau isoforms","volume":"145","author":"Hosokawa","year":"2021","journal-title":"Brain"},{"key":"B40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, A\u03b2 elevation and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"key":"B41","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/978-3-030-78787-5_52","article-title":"Photo-oxygenation: an innovative new therapeutic approach against amyloidoses","volume":"1339","author":"Ikeda","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","article-title":"Tau and neurodegenerative disease: the story so far","volume":"12","author":"Iqbal","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","article-title":"Visualization of A\u03b242(43) and A\u03b240 in senile plaques with end-specific A\u03b2 monoclonals: evidence that an initially deposited species is A\u03b24243","volume":"13","author":"Iwatsubo","year":"1994","journal-title":"Neuron"},{"key":"B44","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer\u2019s Dement."},{"key":"B46","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1523\/JNEUROSCI.3542-15.2016","article-title":"Short fibrils constitute the major species of seed-competent tau in the brains of mice transgenic for human P301S Tau","volume":"36","author":"Jackson","year":"2016","journal-title":"J. Neurosci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1038\/s41467-020-15436-0","article-title":"Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer\u2019s disease","volume":"11","author":"Janelidze","year":"2020","journal-title":"Nat. Commun."},{"key":"B48","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/hmg\/ddh019","article-title":"Mutant presenilins specifically elevate the levels of the 42 residue \u03b2-amyloid peptide in vivo: evidence for augmentation of a 42-specific \u03b3 secretase","volume":"13","author":"Jankowsky","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"B49","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/35050110","article-title":"A\u03b2 peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer\u2019s disease","volume":"408","author":"Janus","year":"2000","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1021\/bi00069a001","article-title":"The carboxy terminus of the \u03b2 amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer\u2019s disease","volume":"32","author":"Jarrett","year":"1993","journal-title":"Biochemistry"},{"key":"B51","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature11283","article-title":"A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline","volume":"488","author":"Jonsson","year":"2012","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer\u2019s disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e42823","DOI":"10.1371\/journal.pone.0042823","article-title":"GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer\u2019s disease","volume":"7","author":"Kamphuis","year":"2012","journal-title":"PLoS One"},{"key":"B54","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ana.410440108","article-title":"Longitudinal study of cerebrospinal fluid levels of tau, A\u03b21\u201340 and A\u03b21\u201342(43) in Alzheimer\u2019s disease: a study in Japan","volume":"44","author":"Kanai","year":"1998","journal-title":"Ann. Neurol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2183\/pjab.90.353","article-title":"Novel plasma biomarker surrogating cerebral amyloid deposition","volume":"90","author":"Kaneko","year":"2014","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","article-title":"The amyloid hypothesis in Alzheimer\u2019s disease: new insights from new therapeutics","volume":"21","author":"Karran","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"B57","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1523\/JNEUROSCI.21-02-00372.2001","article-title":"Age-dependent changes in brain, CSF and plasma amyloid \u03b2 protein in the Tg2576 transgenic mouse model of Alzheimer\u2019s disease","volume":"21","author":"Kawarabayashi","year":"2001","journal-title":"J. Neurosci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"363ra150","DOI":"10.1126\/scitranslmed.aad9704","article-title":"The BACE1 inhibitor verubecestat (MK-8931) reduces CNS \u03b2-amyloid in animal models and in Alzheimer\u2019s disease patients","volume":"8","author":"Kennedy","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of Alzheimer\u2019s disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"B60","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1002\/jcb.26129","article-title":"Dysregulated metabolism of the Amyloid-\u03b2 protein and therapeutic approaches in Alzheimer\u2019s disease","volume":"118","author":"Kikuchi","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"B61","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer\u2019s disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1021\/acs.jmedchem.0c01917","article-title":"Discovery of atabecestat (JNJ-54861911): a thiazine-based \u03b2-amyloid precursor protein cleaving enzyme 1 inhibitor advanced to the phase 2b\/3 EARLY clinical trial","volume":"64","author":"Koriyama","year":"2021","journal-title":"J. Med. Chem."},{"key":"B63","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1073\/pnas.83.11.4044","article-title":"Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer\u2019s disease","volume":"83","author":"Kosik","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B64","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"key":"B65","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.neulet.2005.08.028","article-title":"Exploratory activity and spatial learning in 12-month-old APP(695)SWE\/co+PS1\/DeltaE9 mice with amyloid plaques","volume":"390","author":"Lalonde","year":"2005","journal-title":"Neurosci. Lett."},{"key":"B66","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/s0002-9440(10)63296-8","article-title":"Alzheimer\u2019s disease a\u03b2 vaccine reduces central nervous system a\u03b2 levels in a non-human primate, the Caribbean vervet","volume":"165","author":"Lemere","year":"2004","journal-title":"Am. J. Pathol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.7638622","article-title":"Candidate gene for the chromosome 1 familial Alzheimer\u2019s disease locus","volume":"269","author":"Levy-Lahad","year":"1995","journal-title":"Science (80-)"},{"key":"B68","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/78078","article-title":"Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein","volume":"25","author":"Lewis","year":"2000","journal-title":"Nat. Genet."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41593-019-0433-0","article-title":"TREM2 function impedes tau seeding in neuritic plaques","volume":"22","author":"Leyns","year":"2019","journal-title":"Nat. Neurosci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.nbd.2009.08.007","article-title":"An amyloid-\u03b2 protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer\u2019s disease","volume":"36","author":"Lord","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neurobiolaging.2004.12.007","article-title":"The arctic Alzheimer mutation facilitates early intraneuronal A\u03b2 aggregation and senile plaque formation in transgenic mice","volume":"27","author":"Lord","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"B72","doi-asserted-by":"publisher","first-page":"194re2","DOI":"10.1126\/scitranslmed.3006446","article-title":"Changes in amyloid-\u03b2 and tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein","volume":"5","author":"Maia","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"105115","DOI":"10.1016\/j.neuint.2021.105115","article-title":"Pharmacological relevance of CDK inhibitors in Alzheimer\u2019s disease","volume":"148","author":"Malhotra","year":"2021","journal-title":"Neurochem. Int."},{"key":"B74","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41582-021-00545-1","article-title":"The case for low-level BACE1 inhibition for the prevention of Alzheimer\u2019s disease","volume":"17","author":"McDade","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/nm.3951","article-title":"Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits","volume":"21","author":"Min","year":"2015","journal-title":"Nat. Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1523\/JNEUROSCI.4264-11.2012","article-title":"Differential effects between \u03b3-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice","volume":"32","author":"Mitani","year":"2012","journal-title":"J. Neurosci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/alzrt121","article-title":"Overlapping profiles of A\u03b2 peptides in the Alzheimer\u2019s disease and pathological aging brains","volume":"4","author":"Moore","year":"2012","journal-title":"Alzheimers. Res. Ther."},{"key":"B78","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/35050116","article-title":"A\u03b2 peptide vaccination prevents memory loss in an animal model of Alzheimer\u2019s disease","volume":"408","author":"Morgan","year":"2000","journal-title":"Nature"},{"key":"B79","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/ana.410380413","article-title":"Reduction of \u03b2-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer\u2019s disease","volume":"38","author":"Motter","year":"1995","journal-title":"Ann. Neurol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","article-title":"High-level neuronal expression of A\u03b21\u201342 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation","volume":"20","author":"Mucke","year":"2000","journal-title":"J. Neurosci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"eabc9750","DOI":"10.1126\/sciadv.abc9750","article-title":"Catalytic photooxygenation degrades brain A\u03b2 in vivo","volume":"7","author":"Nagashima","year":"2021","journal-title":"Sci. Adv."},{"key":"B82","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"key":"B83","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0304-3940(95)12160-9","article-title":"Carboxyl end-specific monoclonal antibodies to amyloid \u03b2 protein (A\u03b2) subtypes (A\u03b240 and A\u03b242(43)) differentiate A\u03b2 in senile plaques and amyloid angiopathy in brains of aged cynomolgus monkeys","volume":"201","author":"Nakamura","year":"1995","journal-title":"Neurosci. Lett."},{"key":"B84","doi-asserted-by":"publisher","first-page":"e9316","DOI":"10.15252\/emmm.201809316","article-title":"The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer\u2019s disease","volume":"10","author":"Neumann","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.chempr.2018.02.008","article-title":"Near-infrared photoactivatable oxygenation catalysts of amyloid peptide","volume":"4","author":"Ni","year":"2018","journal-title":"Chem"},{"key":"B86","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm840","article-title":"Neuropathology of human Alzheimer\u2019s disease after immunization with amyloid-\u03b2 peptide: a case report","volume":"9","author":"Nicoll","year":"2003","journal-title":"Nat. Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"101159","DOI":"10.1016\/j.jbc.2021.101159","article-title":"Spreading of Alzheimer tau seeds is enhanced by aging and template matching with limited impact of amyloid-\u03b2","volume":"297","author":"Nies","year":"2021","journal-title":"J. Biol. Chem."},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00614-5","article-title":"Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer\u2019s disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study","volume":"12","author":"Novak","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/oxfordjournals.jbchem.a135625","article-title":"One of the antigenic determinants of paired helical filaments is related to tau protein","volume":"99","author":"Nukina","year":"1986","journal-title":"J. Biochem."},{"key":"B90","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal \u03b2-amyloid aggregates, neurodegeneration and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/s0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular A\u03b2 and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/brain\/awab058","article-title":"Photo-oxygenation by a biocompatible catalyst reduces amyloid-\u03b2 levels in Alzheimer\u2019s disease mice","volume":"144","author":"Ozawa","year":"2021","journal-title":"Brain"},{"key":"B93","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1755-5949.2010.00164.x","article-title":"Review: \u03b3-Secretase inhibitors for the treatment of Alzheimer\u2019s disease: the current state","volume":"16","author":"Panza","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"B94","doi-asserted-by":"publisher","first-page":"8989","DOI":"10.1523\/JNEUROSCI.23-26-08989.2003","article-title":"PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammation","volume":"23","author":"Richards","year":"2003","journal-title":"J. Neurosci."},{"key":"B95","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0197-4580(95)02069-1","article-title":"A\u03b2-associated cerebral angiopathy and senile plaques with neurofibrillary tangles and cerebral hemorrhage in an aged wolverine (Gulo gulo)","volume":"17","author":"Roertgen","year":"1996","journal-title":"Neurobiol. Aging"},{"key":"B96","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/376775a0","article-title":"Familial Alzheimer\u2019s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer\u2019s disease type 3 gene","volume":"376","author":"Rogaev","year":"1995","journal-title":"Nature"},{"key":"B97","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ng1718","article-title":"APP locus duplication causes autosomal dominant early-onset Alzheimer\u2019s disease with cerebral amyloid angiopathy","volume":"38","author":"Rovelet-Lecrux","year":"2006","journal-title":"Nat. Genet."},{"key":"B98","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0896-6273(95)90301-1","article-title":"Dominant and differential deposition of distinct \u03b2-amyloid peptide species, A\u03b2N3(pE), in senile plaques","volume":"14","author":"Saido","year":"1995","journal-title":"Neuron"},{"key":"B99","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nn.3697","article-title":"Single app knock-in mouse models of Alzheimer\u2019s disease","volume":"17","author":"Saito","year":"2014","journal-title":"Nat. Neurosci."},{"key":"B100","doi-asserted-by":"publisher","first-page":"12754","DOI":"10.1074\/jbc.RA119.009487","article-title":"Humanization of the entire murine Mapt gene provides a murine model of pathological human tau propagation","volume":"294","author":"Saito","year":"2019","journal-title":"J. Biol. Chem."},{"key":"B101","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1126\/science.1113694","article-title":"Tau suppression in a neurodegenerative mouse model improves memory function","volume":"309","author":"Santacruz","year":"2005","journal-title":"Science"},{"key":"B102","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-\u03b2 attenuates Alzheimer disease-like pathology in the PDAPP mouse","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"key":"B103","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"B105","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"key":"B106","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1073\/pnas.93.1.452","article-title":"Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer \u03b2-amyloid peptide","volume":"93","author":"Solomon","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"B107","doi-asserted-by":"publisher","first-page":"105120","DOI":"10.1016\/j.nbd.2020.105120","article-title":"Characterization of tau binding by gosuranemab","volume":"146","author":"Sopko","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"B108","doi-asserted-by":"publisher","first-page":"13287","DOI":"10.1073\/pnas.94.24.13287","article-title":"Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology","volume":"94","author":"Sturchler-Pierrat","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"B109","doi-asserted-by":"publisher","first-page":"6165","DOI":"10.1039\/c9cc01728c","article-title":"Photo-oxygenation inhibits tau amyloid formation","volume":"55","author":"Suzuki","year":"2019","journal-title":"Chem. Commun."},{"key":"B110","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nature01506","article-title":"The role of presenilin cofactors in the \u03b3-secratase complex","volume":"422","author":"Takasugi","year":"2003","journal-title":"Nature"},{"key":"B111","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/nchem.2550","article-title":"Switchable photooxygenation catalysts that sense higher-order amyloid structures","volume":"8","author":"Taniguchi","year":"2016","journal-title":"Nat. Chem."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/wnl.58.12.1791","article-title":"Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"B113","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1073\/pnas.94.5.2025","article-title":"The presenilin 2 mutation (N141I) linked to familial Alzheimer\u2019s disease (Volga German families) increases the secretion of amyloid \u03b2 protein ending at the 42nd (or 43rd) residue","volume":"94","author":"Tomita","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B114","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3233\/JAD-140741","article-title":"The murine version of BAN2401 (mAb158) selectively reduces amyloid-\u03b2 protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice","volume":"43","author":"Tucker","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/s41593-020-00737-w","article-title":"Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in life","volume":"23","author":"Uhlmann","year":"2020","journal-title":"Nat. Neurosci."},{"key":"B116","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41582-018-0072-1","article-title":"TREM2 - a key player in microglial biology and Alzheimer\u2019s disease","volume":"14","author":"Ulland","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1046\/j.1460-9568.2003.02444.x","article-title":"Age-dependent cognitive decline in the APP23 model precedes amyloid deposition","volume":"17","author":"Van Dam","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.cvsm.2014.07.008","article-title":"Aging in the canine and feline brain","volume":"44","author":"Vite","year":"2014","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"key":"B119","doi-asserted-by":"publisher","first-page":"31894","DOI":"10.1074\/jbc.271.50.31894","article-title":"The profile of soluble amyloid \u03b2 protein in cultured cell media","volume":"271","author":"Wang","year":"1996","journal-title":"J. Biol. Chem."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.cell.2020.10.029","article-title":"Tau PTM profiles identify patient heterogeneity and stages of Alzheimer\u2019s disease","volume":"183","author":"Wesseling","year":"2020","journal-title":"Cell"},{"key":"B121","doi-asserted-by":"publisher","first-page":"6144","DOI":"10.1523\/JNEUROSCI.1090-04.2004","article-title":"Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition","volume":"24","author":"Wilcock","year":"2004","journal-title":"J. Neurosci."},{"key":"B122","doi-asserted-by":"publisher","first-page":"e59586","DOI":"10.1371\/journal.pone.0059586","article-title":"Neuroinflammation and neuronal loss precede A\u03b2 plaque deposition in the hAPP-J20 mouse model of Alzheimer\u2019s disease","volume":"8","author":"Wright","year":"2013","journal-title":"PLoS One"},{"key":"B123","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3389\/fnins.2017.00667","article-title":"Extracellular tau and its potential role in the propagation of tau pathology","volume":"11","author":"Yamada","year":"2017","journal-title":"Front. Neurosci."},{"key":"B124","doi-asserted-by":"publisher","first-page":"11393","DOI":"10.1523\/JNEUROSCI.2021-09.2009","article-title":"A\u03b2 immunotherapy: Intracerebral sequestration of A\u03b2 by an anti-A\u03b2 monoclonal antibody 266 with high affinity to soluble A\u03b2","volume":"29","author":"Yamada","year":"2009","journal-title":"J. Neurosci."},{"key":"B125","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"B126","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","article-title":"TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy","volume":"90","author":"Yuan","year":"2016","journal-title":"Neuron"},{"key":"B127","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","article-title":"Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer\u2019s disease","volume":"26","author":"Zhou","year":"2020","journal-title":"Nat. Med."}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2022.912995\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T13:50:22Z","timestamp":1655819422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2022.912995\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,21]]},"references-count":126,"alternative-id":["10.3389\/fnmol.2022.912995"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2022.912995","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,21]]},"article-number":"912995"}}